Amer E. Alkhalifa
Irbid, IR 22110, Jordan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
The Impact of the Coexpression of MET and ESR Genes on Prognosticators and Clinical Outcomes of Breast Cancer: An Analysis for the METABRIC Dataset.
Journal: The breast journal
Published: November 24, 2023
Targeting Angiogenesis in Breast Cancer: Current Evidence and Future Perspectives of Novel Anti-Angiogenic Approaches.
Journal: Frontiers in pharmacology
Published: December 17, 2021
Estrogen-Related Receptors Gene Expression and Copy Number Alteration Association With the Clinicopathologic Characteristics of Breast Cancer.
Journal: Breast cancer : basic and clinical research
Published: October 04, 2021
Overcoming resistance to targeted therapy using MET inhibitors in solid cancers: evidence from preclinical and clinical studies.
Journal: Medical oncology (Northwood, London, England)
Published: April 30, 2021
Combined crizotinib and endocrine drugs inhibit proliferation, migration, and colony formation of breast cancer cells via downregulation of MET and estrogen receptor.
Journal: Medical oncology (Northwood, London, England)
Published: November 13, 2020
ING4 Expression Landscape and Association With Clinicopathologic Characteristics in Breast Cancer.
Journal: Clinical breast cancer
Published: July 11, 2020
Crizotinib induced antitumor activity and synergized with chemotherapy and hormonal drugs in breast cancer cells via downregulating MET and estrogen receptor levels.
Journal: Investigational new drugs
Published: June 20, 2020
Discovery of a nanomolar inhibitor of the human glyoxalase-I enzyme using structure-based poly-pharmacophore modelling and molecular docking.
Journal: Journal of computer-aided molecular design
Published: June 03, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026